These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 32001493)
1. PERCEPT myeloma: a protocol for a pilot randomised controlled trial of exercise prehabilitation before and during autologous stem cell transplantation in patients with multiple myeloma. McCourt O; Fisher A; Ramdharry G; Roberts AL; Land J; Rabin N; Yong K BMJ Open; 2020 Jan; 10(1):e033176. PubMed ID: 32001493 [TBL] [Abstract][Full Text] [Related]
2. Exercise prehabilitation for people with myeloma undergoing autologous stem cell transplantation: results from PERCEPT pilot randomised controlled trial. McCourt O; Fisher A; Ramdharry G; Land J; Roberts AL; Rabin N; Yong K Acta Oncol; 2023 Jul; 62(7):696-705. PubMed ID: 36794394 [TBL] [Abstract][Full Text] [Related]
3. "What I wanted to do was build myself back up and prepare": qualitative findings from the PERCEPT trial of prehabilitation during autologous stem cell transplantation in myeloma. McCourt O; Fisher A; Land J; Ramdharry G; Roberts AL; Bekris G; Yong K BMC Cancer; 2023 Apr; 23(1):348. PubMed ID: 37069548 [TBL] [Abstract][Full Text] [Related]
4. IMPROVE-BMT: a protocol for a pilot randomised controlled trial of prehabilitation exercise for adult haematopoietic stem cell transplant recipients. Potiaumpai M; Schmitz KH; Mineishi S; Naik S; Wirk B; Rakszawski K; Ehmann WC; Claxton D; Nickolich M; Zemel BS; Zheng H BMJ Open; 2023 Jan; 13(1):e066841. PubMed ID: 36657760 [TBL] [Abstract][Full Text] [Related]
5. Is it feasible to conduct a randomised controlled trial of pretransplant exercise (prehabilitation) for patients with multiple myeloma awaiting autologous haematopoietic stem cell transplantation? Protocol for the PREeMPT study. Keen C; Skilbeck J; Ross H; Smith L; Collins K; Dixey J; Walters S; Greenfield DM; Snowden JA; Mawson S BMJ Open; 2018 Mar; 8(3):e021333. PubMed ID: 29525775 [TBL] [Abstract][Full Text] [Related]
6. Prehabilitation to improve outcomes afteR Autologous sTem cEll transplantation (PIRATE): A pilot randomised controlled trial protocol. Dennett AM; Porter J; Ting SB; Taylor NF PLoS One; 2023; 18(4):e0277760. PubMed ID: 37104482 [TBL] [Abstract][Full Text] [Related]
7. Adaptation of the PERCEPT myeloma prehabilitation trial to virtual delivery: changes in response to the COVID-19 pandemic. McCourt O; Fisher A; Ramdharry G; Roberts AL; Land J; Rabin N; Rowe K; Yong K BMJ Open; 2022 Apr; 12(4):e059516. PubMed ID: 35396313 [TBL] [Abstract][Full Text] [Related]
8. Investigating the impact of multidisciplinary prehabilitation on deconditioning in patients eligible for haematopoietic allogenic stem cell transplantation: protocol for a feasibility trial. Naumann K; Singh B; Bushaway S; Crane R; Deepak S; Hartland A; Konstantopoulos P; Mansell E; Marinelli V; Pallotta V; Tolfts A; Virieux A; Wall M; Wilksch S; Zhuang M; Atkinson M; Maher C BMJ Open; 2024 Sep; 14(9):e084372. PubMed ID: 39237275 [TBL] [Abstract][Full Text] [Related]
9. Feasibility and benefits of a structured prehabilitation programme prior to autologous stem cell transplantation (ASCT) in patients with myeloma; a prospective feasibility study. Mawson S; Keen C; Skilbeck J; Ross H; Smith L; Dixey J; Walters SJ; Simpson R; Greenfield DM; Snowden JA Physiotherapy; 2021 Dec; 113():88-99. PubMed ID: 34563917 [TBL] [Abstract][Full Text] [Related]
10. Telehealth exercise to Improve Physical function and frailty in patients with multiple myeloma treated with autologous hematopoietic Stem cell transplantation (TIPS): protocol of a randomized controlled trial. Lee K; Nathwani N; Shamunee J; Lindenfeld L; Wong FL; Krishnan A; Armenian S Trials; 2022 Nov; 23(1):921. PubMed ID: 36329525 [TBL] [Abstract][Full Text] [Related]
11. Design of the EXercise Intervention after Stem cell Transplantation (EXIST) study: a randomized controlled trial to evaluate the effectiveness and cost-effectiveness of an individualized high intensity physical exercise program on fitness and fatigue in patients with multiple myeloma or (non-) Hodgkin's lymphoma treated with high dose chemotherapy and autologous stem cell transplantation. Persoon S; Kersten MJ; Chinapaw MJ; Buffart LM; Burghout H; Schep G; Brug J; Nollet F BMC Cancer; 2010 Dec; 10():671. PubMed ID: 21134270 [TBL] [Abstract][Full Text] [Related]
12. Preventing the adverse cardiovascular consequences of allogeneic stem cell transplantation with a multi-faceted exercise intervention: the ALLO-Active trial protocol. Dillon HT; Saner NJ; Ilsley T; Kliman D; Spencer A; Avery S; Dunstan DW; Daly RM; Fraser SF; Owen N; Lynch BM; Kingwell BA; La Gerche A; Howden EJ BMC Cancer; 2022 Aug; 22(1):898. PubMed ID: 35978289 [TBL] [Abstract][Full Text] [Related]
13. Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation. Ikeda T; Mori K; Kawamura K; Mori T; Hagiwara S; Ueda Y; Kahata K; Uchida N; Tsukada N; Murakami S; Yamamoto M; Takahashi T; Ichinohe T; Onizuka M; Atsuta Y; Kanda Y; Okamoto S; Sunami K; Takamatsu H Hematol Oncol; 2019 Dec; 37(5):586-594. PubMed ID: 31674032 [TBL] [Abstract][Full Text] [Related]
14. Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial. Royle KL; Coulson AB; Ramasamy K; Cairns DA; Hockaday A; Quezada S; Drayson M; Kaiser M; Owen R; Auner HW; Cook G; Meads D; Olivier C; Barnard L; Lambkin R; Paterson A; Dawkins B; Chapman M; Pratt G; Popat R; Jackson G; Bygrave C; Sive J; de Tute R; Chantry A; Parrish C; Cook M; Asher S; Yong K BMJ Open; 2022 Nov; 12(11):e063037. PubMed ID: 36396306 [TBL] [Abstract][Full Text] [Related]
15. Feasibility and acceptability of PrE-operative Physical Activity to improve patient outcomes After major cancer surgery: study protocol for a pilot randomised controlled trial (PEPA Trial). Steffens D; Young J; Beckenkamp PR; Ratcliffe J; Rubie F; Ansari N; Pillinger N; Solomon M Trials; 2018 Feb; 19(1):112. PubMed ID: 29452599 [TBL] [Abstract][Full Text] [Related]
16. Optimized patient-trajectory for patients undergoing treatment with high-dose chemotherapy and autologous stem cell transplantation. Bartels FR; Smith NS; Gørløv JS; Grufstedt HK; Nexø C; Kehlet H; Sjøgren P; Kjeldsen L; Høgdal N Acta Oncol; 2015 May; 54(5):750-8. PubMed ID: 25761093 [TBL] [Abstract][Full Text] [Related]
17. Feasibility and safety of exercise training and nutritional support prior to haematopoietic stem cell transplantation in patients with haematologic malignancies. Rupnik E; Skerget M; Sever M; Zupan IP; Ogrinec M; Ursic B; Kos N; Cernelc P; Zver S BMC Cancer; 2020 Nov; 20(1):1142. PubMed ID: 33234112 [TBL] [Abstract][Full Text] [Related]
18. i-Move, a personalised exercise intervention for patients with advanced melanoma receiving immunotherapy: a randomised feasibility trial protocol. Hyatt A; Gough K; Murnane A; Au-Yeung G; Dawson T; Pearson E; Dhillon H; Sandhu S; Williams N; Paton E; Billett A; Traill A; Andersen H; Beedle V; Milne D BMJ Open; 2020 Feb; 10(2):e036059. PubMed ID: 32114479 [TBL] [Abstract][Full Text] [Related]
19. Thalidomide before and after autologous stem cell transplantation in recently diagnosed multiple myeloma (HOVON-50): long-term results from the phase 3, randomised controlled trial. van de Donk NW; van der Holt B; Minnema MC; Vellenga E; Croockewit S; Kersten MJ; von dem Borne PA; Ypma P; Schaafsma R; de Weerdt O; Klein SK; Delforge M; Levin MD; Bos GM; Jie KG; Sinnige H; Coenen JL; de Waal EG; Zweegman S; Sonneveld P; Lokhorst HM Lancet Haematol; 2018 Oct; 5(10):e479-e492. PubMed ID: 30290905 [TBL] [Abstract][Full Text] [Related]
20. PRehabIlitatiOn with pReoperatIve exercise and educaTion for patients undergoing major abdominal cancer surgerY: protocol for a multicentre randomised controlled TRIAL (PRIORITY TRIAL). Steffens D; Young J; Riedel B; Morton R; Denehy L; Heriot A; Koh C; Li Q; Bauman A; Sandroussi C; Ismail H; Dieng M; Ansari N; Pillinger N; O'Shannassy S; McKeown S; Cunningham D; Sheehan K; Iori G; Bartyn J; Solomon M BMC Cancer; 2022 Apr; 22(1):443. PubMed ID: 35459100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]